Clinical Trial Update: Tucidinostat Plus Apatinib for Advanced Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating tucidinostat plus apatinib for advanced osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Apatinib (apatinib)
• Tucidinostat (tucidinostat)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Osteosarcoma | Phase 2 | Status: UNKNOWN